Evidence map›Paper›PMID 30084157›Full record

ArticleJournal of veterinary internal medicine2018

Efficacy of tamoxifen for the treatment of severe equine asthma.

Sophie Mainguy-Seers, Khristine Picotte, Jean-Pierre Lavoie

Open access · goldAbstract readClinical Trial, Veterinary
In one paragraph

Article in Journal of veterinary internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tamoxifen triggers theFrontiers in veterinary science · 2022
    Article
  5. Review
  6. Glucocorticoid treatment in horses with asthma: A narrative review.Journal of veterinary internal medicine · 2021
    Review
  7. Article
  8. Article
  9. Efficacy of tamoxifen for the treatment of severe equine asthma.Journal of veterinary internal medicine · 2018
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sophie Mainguy-SeersFaculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, QC, Canada.ORCID http://orcid.org/0000-0002-4768-6674
Khristine PicotteFaculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, QC, Canada.
Jean-Pierre LavoieFaculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, QC, Canada.
Cegep de Saint Hyacinthe · CA

Funding

Canadian Institutes of Health ResearchEquine Research Fund of the Université de Montréal (unrestricted grant from Zoetis)
6 · The paper itself

Abstract

backgroundTamoxifen, a selective estrogen receptor modulator, decreased airway neutrophilia and improved clinical signs in an experimental model of equine asthma, and induced neutrophilic apoptosis in vitro. HYPOTHESIS/

objectivesTamoxifen reduces airway neutrophilia and improves lung function in severe asthmatic horses. ANIMALS: Twelve severe asthmatic horses from a research herd.

methodsRandomized controlled blinded study design. The effects of a 12-day oral treatment with tamoxifen (0.22 mg/kg, q24h) or dexamethasone (0.06 mg/kg, q24h) on lung function, endoscopic tracheal mucus score and bronchoalveolar lavage fluid cytology were compared.

resultsTamoxifen significantly improved the pulmonary resistance (R CONCLUSIONS AND CLINICAL IMPORTANCE: Results of this study do not support the use of tamoxifen at the dose studied as an antineutrophilic medication in the treatment of asthmatic horses in chronic exacerbation.

Indexed as

AnimalsAsthmaBronchoalveolar Lavage FluidFemaleHorse DiseasesHorsesMaleRandom AllocationSelective Estrogen Receptor ModulatorsTamoxifenSelective Estrogen Receptor ModulatorsTamoxifenairway neutrophiliadexamethasoneestrogenheaves

Identifiers

PMID30084157
PMCPMC6189378
OpenAlexW2885557044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.